CN101310735B - Traditional Chinese drug pelletized granule for reducing fever, detoxifying, diminishing inflammation and preparation method thereof - Google Patents
Traditional Chinese drug pelletized granule for reducing fever, detoxifying, diminishing inflammation and preparation method thereof Download PDFInfo
- Publication number
- CN101310735B CN101310735B CN2007100995077A CN200710099507A CN101310735B CN 101310735 B CN101310735 B CN 101310735B CN 2007100995077 A CN2007100995077 A CN 2007100995077A CN 200710099507 A CN200710099507 A CN 200710099507A CN 101310735 B CN101310735 B CN 101310735B
- Authority
- CN
- China
- Prior art keywords
- weight portions
- extract
- acute
- granule
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The invention provides a traditional Chinese medicine sugar-free granule for treating acute and chronic tonsillitis, acute and chronic pharyngitis and upper respiratory tract infection and a preparation method thereof, and the granules are prepared by honeysuckle flower extract and baical skullcap root extract according to a certain proportion. The granules of the invention are applicable to various people groups, and the clinical efficacy is significantly improved.
Description
Technical field
The present invention relates to treat the acute and chronic tonsillitis, acute and chronic pharyngitis, method for preparing of the Chinese medicine granules of upper respiratory tract infection disease and products thereof belongs to technical field of Chinese medicines.
Background technology
Acute and chronic tonsillitis, acute and chronic pharyngitis, upper respiratory tract infection are many to be caused by flu, belongs to common susceptible disease, especially in stage occurred frequently of this type of respiratory system disease especially autumn and winter season.The medicine of treating this type of disease is innumerable especially, and western medicine is many to be main with Tri-Biocin, antipyretic-antalgic class medicine and antiviral class medicine, though the Western medicine instant effect is easy to generate drug resistance, and too much use also can cause other diseases of human body.Use this type of disease of treatment by Chinese herbs then can avoid the shortcoming of above-mentioned Western medicine, but it is uneven to treat the Chinese patent medicine curative effect of this type of disease at present, many medicines all can not reach the advantage of instant effect.
Silver yellow class preparation is exactly to treat acute and chronic tonsillitis, acute and chronic pharyngitis, upper respiratory tract infection effect one type of medicine preferably in the market.National standards such as YINHUANG CHONGJI, oral liquid, capsule, tablet have all been carried out for many years, and its standard of silver yellow granule is recorded in the 6th of ministry standard, and prescription is made up of Flos Lonicerae extract 100g, Radix Scutellariae extract 40g; Method for making is above two flavors, and is an amount of with sucrose 800g and starch, stirs; Process granule; Dry below 60 ℃, process 1000g, promptly get.Wherein the method for preparing of Flos Lonicerae extract is an extracting honeysuckle, decocte with water secondary, each 2 hours, collecting decoction; Filter, filtrating adds lime cream and is adjusted to pH value to 10～12, leaves standstill the leaching deposition; Add suitable quantity of water, add sulphuric acid and regulate pH value to 6～7, stir; Filter, filtrating is concentrated into the thick paste shape, promptly gets.The method for preparing of Radix Scutellariae extract adds to and decocts secondary in the boiling water for getting Radix Scutellariae, and each 1 hour, collecting decoction filtered filtrating and adds sulphuric acid adjusting pH value to 2, leave standstill, and the leaching deposition, after an amount of washing of ethanol, drying promptly gets.Though the silver yellow granule have dissolving absorb fast, bioavailability is high, mouthfeel is good, is convenient to take advantage such as carry; But added a large amount of sucrose in this granule; Taking dose is strengthened, and be unwell to some and be difficult for taking sacchariferous patient, for example diabetics.Moreover because what use is conventional granulation in this technology, and sucrose plays an important role in granulation, if change other adjuvants into, the unsuitable molding of granule should not be granulated.So provides a kind of and be applicable to that any patient takes, curative effect is high, and the medicine that is easy to granulate and preparation method thereof is practicable.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of any patient of being fit to take, and curative effect of medication is high, and the granule that is easy to granulate and preparation method thereof.
The medicine of treatment acute and chronic tonsillitis provided by the invention, acute and chronic pharyngitis, upper respiratory tract infection is prepared from following steps:
1) extracting honeysuckle, the decocte with water secondary, each 2 hours, collecting decoction filtered; Filtrating adds lime cream and regulates pH value to 10～12, leaves standstill, and the leaching deposition adds suitable quantity of water, adds sulphuric acid and regulates pH value to 6～7; Stir, filter, filtrating is concentrated into the thick paste shape, gets Flos Lonicerae extract;
2) get Radix Scutellariae, add to and decoct secondary in the boiling water, each 1 hour, collecting decoction filtered, and filtrating adds sulphuric acid adjusting pH value to 2, leave standstill, and the leaching deposition, after an amount of washing of ethanol, drying gets Radix Scutellariae extract;
3) take by weighing the Flos Lonicerae extract and the step 2 of step 1) in the 5:2 ratio) Radix Scutellariae extract, add the adjuvant except that sucrose after, stir, process granule, promptly get.
Adjuvant in the above step 3) except that the sugarcane candy is one or more the compositions in pharmaceutic adjuvant tangerine sugar, xylitol, fructose, mannitol, sorbitol, lactose, starch, the dextrin, the mixture of preferred tangerine sugar and dextrin; Selected method of granulating is spray granulation method, boiling granulating method and extrusion granulator method in the step 3), is preferably the boiling granulating method; The granule that application the present invention makes is a sugar-free granule.
Process conditions preferred:
1) selection of method of granulating
To spray granulation method, boiling granulating method, the prepared granule of extrusion granulator method that adopts in the technology; Press commercially available back; Adopt the water isolation type electro-heating standing-temperature cultivator,, and can monitor true temperature and humidity at 40 ± 2 ℃ of temperature, relative humidity 75 ± 5%.Take a sample respectively once 1st month, 2 months, 3 months, 6 the end of month at duration of test, press the study on the stability project and detect.
Below be several kinds of method of granulating gained drug quality study on the stability results' comparison, the result sees the following form:
3 kinds of method of granulating medicine stabilities are investigated the result
"+" expression meets quality of the pharmaceutical preparations requirement.
Above result shows: the method for granulating technology stability is followed successively by the boiling granulating method>the spray granulation method>the extrusion granulator method.The boiling granulating method is to utilize air-flow powder suspension, is fluidization, sprays into adhesive liquid again, makes the powder granulating that condenses.Feeding gas flow temperature can regulate according to the production needs.Flos Lonicerae extract in the medicine of the present invention, its active ingredient chlorogenic acid is poor stability under higher temperature, is prone to decompose.After adopting the boiling granulating method in the method for preparing; Make its dry and step completion of granulating; Baking temperature be effectively controlled (40 ℃～55 ℃); Effective ingredient is difficult for loss, make in the preparation active constituent content obtain significance and improve, and the granule melting that this method makes is good, epigranular, storage for a long time are difficult for hardening.In line with the factor of aspects such as constant product quality property, evident in efficacy and energy savings, select for use the boiling granulating method to carry out particulate preparation.
2) selection of adjuvant
The selection of the supplementary product kind of granule and usage ratio; The quality of the pharmaceutical preparations and curative effect to medicine have the significance influence; In order to find out the optimum amount ratio of best supplementary product kind and raw material and adjuvant, the inventor has carried out lot of test, below is the part test of being implemented:
Take by weighing Flos Lonicerae extract and Radix Scutellariae extract in proportion; The adjuvant that adds variety classes and ratio is respectively granulated with the boiling granulating method, investigates from the complexity of granulating, particulate appearance character and three aspects of particulate hygroscopicity; Confirm the selection percentage of adjuvant, the result sees the following form:
The selection of adjuvant
Can find out from last table,, not only granulate easily, and the particle appearance character that makes be good, measure the moisture content change minimum after three months through fuchsin(e)test when medicine, dextrin, when the tangerine sugar proportioning is 7:18:0.125.
The specific embodiment
The following further explain method for preparing with Chinese medicine sugar-free granule of heat clearing away, detoxifcation, inflammation-diminishing function of the present invention, but therefore the present invention does not receive any restriction.
[embodiment 1] takes by weighing Flos Lonicerae extract 100 weight portions, baicalin extract 40 weight portions, adds dextrin 360 weight portions and tangerine sugar 5 ‰ weight portions, and mix homogeneously is granulated with the boiling granulating method, promptly gets.
[embodiment 2] take by weighing Flos Lonicerae extract 200 weight portions, baicalin extract 80 weight portions, add dextrin 720 weight portions and tangerine sugar 5 ‰ weight portions, and mix homogeneously is granulated with the boiling granulating method, promptly gets.
[embodiment 3] take by weighing Flos Lonicerae extract 100 weight portions, baicalin extract 40 weight portions, add dextrin 360 weight portions and tangerine sugar 5 ‰ weight portions, and mix homogeneously is granulated with the extrusion granulator method, promptly gets.
[embodiment 4] take by weighing Flos Lonicerae extract 100 weight portions, baicalin extract 40 weight portions, add dextrin 360 weight portions and tangerine sugar 5 ‰ weight portions, and mix homogeneously is granulated with the spray granulation method, promptly gets.
[embodiment 5] take by weighing Flos Lonicerae extract 100 weight portions, baicalin extract 40 weight portions, add starch 360 weight portions and tangerine sugar 5 ‰ weight portions, and mix homogeneously is granulated with the boiling granulating method, promptly gets.
[embodiment 6] take by weighing Flos Lonicerae extract 100 weight portions, baicalin extract 40 weight portions, add lactose 360 weight portions and tangerine sugar 2.5 ‰ weight portions, and mix homogeneously is granulated with the boiling granulating method, promptly gets.
[embodiment 7] take by weighing Flos Lonicerae extract 100 weight portions, baicalin extract 40 weight portions, add dextrin 360 weight portions and mannitol 5 ‰ weight portions, and mix homogeneously is granulated with the boiling granulating method, promptly gets.
[embodiment 8] take by weighing Flos Lonicerae extract 100 weight portions, baicalin extract 40 weight portions, add xylitol 360 weight portions, and mix homogeneously is granulated with the boiling granulating method, promptly gets.
[embodiment 9] take by weighing Flos Lonicerae extract 100 weight portions, baicalin extract 40 weight portions, add sorbitol 360 weight portions, and mix homogeneously is granulated with the boiling granulating method, promptly gets.
[embodiment 10] take by weighing Flos Lonicerae extract 100 weight portions, baicalin extract 40 weight portions, add fructose 360 weight portions and tangerine sugar 2.5 ‰ weight portions, and mix homogeneously is granulated with the boiling granulating method, promptly gets.
[embodiment 11] take by weighing Flos Lonicerae extract 100 weight portions, baicalin extract 40 weight portions, add fructose 360 weight portions and mannitol 2.5 ‰ weight portions, and mix homogeneously is granulated with the boiling granulating method, promptly gets.
One, pharmacodynamics test:
1, trial drug: the positive controls medicine, produce by Jiahe, Guangzhou pharmaceutical factory;
Drug group medicine of the present invention is according to the prepared sugar-free granule of embodiment 1;
The negative control group medicine is normal saline solution.
2, test method:
1) heat clearing away effect:
Get the white big ear rabbit of body weight at 2.0～3.0kg, male and female have concurrently, experiment the previous day choose body temperature at 38.0～39.4 ℃, and body temperature changed the rabbit be no more than 0.4 ℃ and used rabbit as experiment the same day.On the same day, measure basal body temperature before the modeling, oneself rabbit ear vein bacterial injection endotoxin normal saline solution; Dosage is 7.5g; Observation body temperature changes, per 0.5 hour record once, choose injection 1h after body temperature rise surpass 0.5 ℃ rabbit; Be divided into 5 groups at random, 8 every group: the large, medium and small dose groups of medicine of the present invention, positive controls.Irritate stomach to rabbit, after the administration, continue to observe rabbit body temperature and change, per 1 hour record once, continuous record 5h is an observation index with the animal heat of every 1h and the difference of basal body temperature, the result sees the following form.
Table 3 rabbit pyrogenic test result
Annotate: < 0.05, < 0.01, drug group of the present invention and positive controls be △ P < 0.05 relatively for * * P to compare * P with negative control group.
The result shows: medicine of the present invention and silver yellow granule matched group relatively have the significance inhibitory action to fever in rabbits due to the bacterial endotoxin, have the effect of heat clearing away.
2) Detoxication:
Experiment was surveyed body temperature 3 in advance with rat, and experiment measured value on the same day is the rat basal body temperature, and the variation of screening body temperature is no more than 0.3 ℃ animal; Be divided into 5 groups at random; Every group 13: silver yellow granule positive controls, the large, medium and small dosage of medicine of the present invention, behind the gastric infusion, inject 1% carrageenin solution 0.1ml under the rat right hind leg sole immediately; Record causes before the inflammation and causes scorching back 1～6h rat foot volume, and calculating swelling rate.
Table 4 rat foot is to scorching result of the test
Annotate: < 0.05, < 0.01, drug group of the present invention and positive controls be △ P < 0.05 relatively for * * P to compare * P with negative control group.
The result shows: drug group of the present invention and the comparison of silver yellow granule matched group can significantly suppress the volume of rat swelling sole, have antibacterial antidotal effect.
Two, clinical trial
1.1 case is selected early stage, light-duty acute pharyngitis patient 300 examples, male 153 examples, women 147 examples, 13～69 years old age, average 38.4 years old.With severe cases: (1) hyperpyrexia (body temperature >=40 ℃); (2) course of disease >=3d companion body temperature>39 ℃; (3) purulence angina patient all gives and forgoing.Except causing that in addition for having used antibiotic before examining, and by general disease (like hematopathy etc.) pharyngeal the infected also.
1.2 test divides into groups 300 routine patients are divided into 2 groups at random
Drug group 200 examples of the present invention, male 102 examples, women 98 examples.Take the granule of the embodiment of the invention 1 preparation, every day 2 times, each 4g avoids maror.
Matched group 100 examples, male 51 examples, women 49 examples.Silver yellow granule every day of taking that Jiahe, Guangzhou pharmaceutical factory produces 2 times, each 8g avoids maror.
1.3 clinical observation project and efficacy assessment standard
1.3.1 observation item comprises symptom pharyngalgia, dry pharynx sense, dysphagia, pharynx foreign body sensation, cough and expectoration, heating etc.Sign: pharyngeal mucous membrane hyperemia, the congested swelling of lateral pharyngeal band, pharyngeal exudate, submandibular lymph nodes enlargement and tenderness etc.Check behind the medication 3d.
1.3.2 judge grade scale (1) produce effects of curative effect: subjective symptoms and positive sign disappear or complete obiteration basically; (2) effective: subjective symptoms and positive sign alleviate; (3) invalid: symptom and sign do not have and alleviate.Total effective rate=produce effects+effectively/total routine number * 100%.
2 results
2.1 treatment acute pharyngitis doing well,improving situation, the back acute pharyngitis patient's that takes medicine various symptoms all have the different improvement of degree, are improved as outstanding with pharyngalgia, pharynx foreign body sensation, cough and expectoration and heating etc. especially.The result sees table 1.
Table 1 a treatment acute pharyngitis doing well,improving situation (example)
* drug group of the present invention and matched group P < 0.05
Can find out from last table, drug group of the present invention and the matched group preceding clinical symptoms there was no significant difference of taking medicine, the back drug group clinical symptoms improvement ratio of the present invention of taking medicine is significantly higher than matched group.
2.2 treatment acute pharyngitis sign is improved situation, the back acute pharyngitis patient's that takes medicine various signs all have improvement, and are wherein congested with pharyngeal mucous membrane hyperemia and lateral pharyngeal band, swelling is particularly evident.The result sees table 2.
Table 2 treatment acute pharyngitis sign is improved situation (example)
* drug group of the present invention and matched group P < 0.05
Can find out from last table, drug group of the present invention and the matched group preceding clinical sign there was no significant difference of taking medicine, the back drug group clinical sign improvement ratio of the present invention of taking medicine is significantly higher than matched group.
2.3 the curative effect of treatment acute pharyngitis, the result sees table 3.
The curative effect (example) of table 3 treatment acute pharyngitis
| Total routine number | Produce effects | Effectively | Invalid | Total effective rate | |
| Drug group of the present invention | 200 | 117 | 51 | 32 | 94％* |
| Matched group | 100 | 66 | 19 | 15 | 85％ |
* drug group of the present invention and matched group P < 0.05
Can find out from last table, of the present invention group of medicine to the total effective rate of treatment acute pharyngitis apparently higher than matched group.Drug therapy of the present invention reaches light-duty acute pharyngitis effective percentage in early days and reaches 94%, and does not have obvious toxic-side effects, and 200 routine patients do not find any untoward reaction at period in a medicine.
Claims (2)
1. one kind is used for the acute and chronic tonsillitis, acute and chronic pharyngitis, and the Chinese medicine granules of upper respiratory tract infection is prepared from according to following steps:
1) extracting honeysuckle, the decocte with water secondary, each 2 hours, collecting decoction filtered; Filtrating adds lime cream and regulates pH value to 10～12, leaves standstill, and the leaching deposition adds suitable quantity of water, adds sulphuric acid and regulates pH value to 6～7; Stir, filter, filtrating is concentrated into the thick paste shape, gets Flos Lonicerae extract;
2) get Radix Scutellariae, add to and decoct secondary in the boiling water, each 1 hour, collecting decoction filtered, and filtrating adds sulphuric acid adjusting pH value to 2, leave standstill, and the leaching deposition, after an amount of washing of ethanol, drying gets Radix Scutellariae extract;
3) take by weighing the Flos Lonicerae extract and the step 2 of step 1) in 5: 2 ratios) Radix Scutellariae extract, add the adjuvant except that sucrose after, stir, the boiling granulating method is processed granule, promptly gets.
2. Chinese medicine granules as claimed in claim 1 is characterized in that the adjuvant in the step 3 is dextrin, tangerine sugar, and medicine, dextrin, tangerine sugar proportioning are 7: 18: 0.125.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007100995077A CN101310735B (en) | 2007-05-23 | 2007-05-23 | Traditional Chinese drug pelletized granule for reducing fever, detoxifying, diminishing inflammation and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007100995077A CN101310735B (en) | 2007-05-23 | 2007-05-23 | Traditional Chinese drug pelletized granule for reducing fever, detoxifying, diminishing inflammation and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101310735A CN101310735A (en) | 2008-11-26 |
| CN101310735B true CN101310735B (en) | 2012-02-29 |
Family
ID=40099691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007100995077A Active CN101310735B (en) | 2007-05-23 | 2007-05-23 | Traditional Chinese drug pelletized granule for reducing fever, detoxifying, diminishing inflammation and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101310735B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101744883B (en) * | 2008-12-19 | 2011-12-07 | 北京亚东生物制药有限公司 | Chinese medicinal composition preparation and preparation method thereof and quality control method |
| CN105497133A (en) * | 2015-12-19 | 2016-04-20 | 昆明赛诺制药有限公司 | Periplaneta Americana medicine composition for treating pharyngitis and tonsillitis and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1069881A (en) * | 1992-09-08 | 1993-03-17 | 四川省中药厂 | The preparation method of antivirus powder without sugar |
| CN1565585A (en) * | 2003-06-30 | 2005-01-19 | 浙江大德制药有限公司 | Preparing method of sugar free medicinal granule |
| CN1582972A (en) * | 2003-08-19 | 2005-02-23 | 武汉健民集团随州药业有限公司 | Sugarless Xiasangju granules |
| CN1657048A (en) * | 2004-02-21 | 2005-08-24 | 李文东 | Laminaran granule and its preparation technology |
-
2007
- 2007-05-23 CN CN2007100995077A patent/CN101310735B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1069881A (en) * | 1992-09-08 | 1993-03-17 | 四川省中药厂 | The preparation method of antivirus powder without sugar |
| CN1565585A (en) * | 2003-06-30 | 2005-01-19 | 浙江大德制药有限公司 | Preparing method of sugar free medicinal granule |
| CN1582972A (en) * | 2003-08-19 | 2005-02-23 | 武汉健民集团随州药业有限公司 | Sugarless Xiasangju granules |
| CN1657048A (en) * | 2004-02-21 | 2005-08-24 | 李文东 | Laminaran granule and its preparation technology |
Non-Patent Citations (1)
| Title |
|---|
| 中华人民共和国药典委员会.银黄冲剂.《卫生部颁药品标准中药成方制剂第六册》.1992,169. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101310735A (en) | 2008-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101366844B (en) | New use of loquat flower and its extract | |
| CN102526355A (en) | Chinese medicinal compound preparation for resisting virus and treating flu and cold | |
| CN102319294B (en) | Double-vanilla preparation and preparation method thereof | |
| CN101167898A (en) | Traditional Chinese medicine preparation for treating insomnia | |
| CN102805776B (en) | Traditional Chinese medicine composition and preparation method of traditional Chinese medicine composition | |
| CN101474375A (en) | Compound Cordyceps militaris L. Link preparation and production method and application | |
| CN101310735B (en) | Traditional Chinese drug pelletized granule for reducing fever, detoxifying, diminishing inflammation and preparation method thereof | |
| CN101322761A (en) | Medicament for treating tracheitis and bronchitic and preparation thereof | |
| CN102302672A (en) | Honeysuckle flower buccal tablets and preparation method thereof | |
| CN101843659A (en) | Traditional Chinese medicine granular formulation for preventing and treating influenza and preparation method thereof | |
| CN101406629A (en) | Buccal tablets for treating painful swelling of gingiva and preparation method thereof | |
| CN101716300B (en) | Cough relief traditional Chinese medicine compound preparation and preparation method thereof | |
| CN102441064B (en) | Traditional Chinese medicine composition for treating diabetes and preparation thereof | |
| CN101837046A (en) | Anti-virus Chinese medicinal preparation and preparation method thereof | |
| CN101411752A (en) | Granular formulation for treating children's pneumonia | |
| CN1899392B (en) | Chinese medicine composition for treating gynecological inflammation and its preparing method and use | |
| CN116098224A (en) | Pressed candy for regulating uric acid and preparation method thereof | |
| CN101700326B (en) | Preparation method of traditional Chinese medicine preparation for clearing heat and promoting urination for treating stranguria | |
| CN107095936B (en) | Traditional Chinese medicine composition for detoxifying and relieving sore throat as well as preparation method and application thereof | |
| CN101607032B (en) | Compound medicament for treating children cough and preparation method thereof | |
| CN107802676B (en) | Lilac extract and preparation method and application thereof | |
| CN103432375A (en) | Preparation method of traditional Chinese medicine extract with effects of ventilating lung, clearing heat, resolving phlegm and relieving cough | |
| CN113425767B (en) | Traditional Chinese medicine composition for treating pneumonia | |
| CN103230568B (en) | Benorilate vitamin B1 particle for children and preparation process thereof | |
| CN101797263B (en) | Traditional Chinese medicine composite for antibiosis and antiphlogosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |